Round 1 | Round 2 | ||||
---|---|---|---|---|---|
Indicator | Feasibility | Validity | Status | Validity | Status |
Number of clinical trials | 81% | 84% | Included | – | Included |
Percentage of patients included in a clinical trial | 77% | 81% | Included | – | Included |
Number of peer-reviewed publications | 95% | 81% | Included | – | Included |
Number of citations | 88% | 85% | Included | – | Included |
Number of public-private partnerships | 75% | 78% | Included | – | Included |
Impact factor | 96% | 76% | Included | – | Included |
Institutional h-index | 92% | 73% | Second round | 83% | Included |
Number of publications co-authored with another organisation | 92% | 72% | Second round | 76% | Included |
Mean number of citations per article | 91% | 69% | Second round | 66% | Included |
Number of highly cited publications | 78% | 67% | Second round | 69% | Included |
Number of publications in top-ranked journals | 85% | 65% | Second round | 69% | Included |
z-index | 83% | 71% | Second round | 69% | Included |
Number of publications with international collaboration | 92% | 67% | Second round | 85% | Included |
Number of biomarkers identified | 33% | 52% | Modified | 58% | To be discussed |
Citation of research in clinical guidelines | 71% | 71% | Second round | 62% | To be discussed |
Generation of clinical guidelines | 74% | 67% | Second round | 54% | To be discussed |
Citation of research in public health guidelines | 60% | 58% | Modified | 50% | To be discussed |
Number of patents | 88% | 65% | Second round | 38% | Excluded |
Number of patients in a clinical trial with a biomarker identification | 56% | 58% | Excluded | – | – |
Number of biological samples collected | 69% | 50% | Excluded | – | – |
Number of biological samples transmitted | 42% | 34% | Excluded | – | – |
Number of hypotheses generated | 46% | 46% | Excluded | – | – |
Number of diagnostic tests created | 50% | 45% | Excluded | – | – |
Number of database generated | 50% | 38% | Excluded | – | – |
Number of research projects ongoing | 57% | 29% | Excluded | – | – |
Number of assays developed | 0% | 0% | Excluded | – | – |
Number of visits to EXPASY server | 75% | 0% | Excluded | – | – |
Clinicians’ awareness of research results | 22% | 36% | Excluded | – | – |
Changes in clinical practices | 21% | 43% | Excluded | – | – |
Contribution to reports informing policy makers | 58% | 35% | Excluded | – | – |
Number of presentations at key selected conferences | 60% | 56% | Excluded | – | – |
Citation in medical education books | 42% | 48% | Excluded | – | – |
Number of conferences held | 71% | 38% | Excluded | – | – |
Citation of research in the media | 41% | 28% | Excluded | – | – |
Number of papers co-authored with the industry | 74% | 61% | Excluded | – | |
Citation of research in patents | 79% | 58% | Excluded | – | – |
Patent h-index | 52% | 52% | Excluded | – | – |
Number of patent citations | 73% | 48% | Excluded | – | – |
Number of spin-off companies created | 86% | 43% | Excluded | – | – |
Partnership-ability index | 82% | 50% | Excluded | – | – |
Dependence degree (d-index) | 67% | 50% | Excluded | – | – |
Proportion of long-distance collaborative publications | 43% | 0% | Excluded | – | – |
Number of publications co-authored by an epidemiologist and biologist | 52% | 41% | Excluded | – | – |
Age-weighted citation rate | 71% | 33% | Excluded | – | – |
b-index | 83% | 43% | Excluded | – | – |
Central index | 60% | 50% | Excluded | – | – |
CH-index | 50% | 0% | Excluded | – | – |
Crown indicator | 33% | 0% | Excluded | – | – |
e-index | 80% | 50% | Excluded | – | – |
g-index | 100% | 0% | Excluded | – | – |
Hg-index | 33% | 0% | Excluded | – | – |
j-index | 75% | 33% | Excluded | – | – |
m-index | 50% | 25% | Excluded | – | – |
m-quotient | 67% | 60% | Excluded | – | – |
Mean normalised citation score | 50% | 33% | Excluded | – | – |
Q2 index | 25% | 0% | Excluded | – | – |
r-index | 83% | 33% | Excluded | – | – |
SP-index | 100% | 50% | Excluded | – | – |
w-index | 71% | 33% | Excluded | – | – |
x-index | 50% | 0% | Excluded | – | – |